Trials / Withdrawn
WithdrawnNCT05394181
Notify 2: An Evaluation of the Impact of Notification of Incidental Coronary Artery Calcium on Statin Rates
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to estimate the impact of notification of primary care provider and patient of at least moderate incidental coronary artery calcification (CAC) on a prior non-gated chest CT on statin prescription rates at 4 months among patients without a clinical history of atherosclerotic cardiovascular disease not actively on statin therapy. This study will determine if notifying patients and their primary care clinician about an existing finding will influence shared decision-making around statins between patients and their primary care clinician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Notification | Notification of patient and primary care clinician of presence of at least moderate coronary artery calcium on a prior non-gated chest CT |
Timeline
- Start date
- 2022-08-01
- Primary completion
- 2023-01-15
- Completion
- 2023-03-15
- First posted
- 2022-05-27
- Last updated
- 2026-02-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05394181. Inclusion in this directory is not an endorsement.